Company: ZVRA
Filing Date: 2025-08-12
Form Type: 10-Q
Source: 0001628280-25-039967
Chunk: 127

Company: ZEVRA THERAPEUTICS, INC.
Filing Date: 2025-08-12
Form: 10-Q
Item: Part I, Item 8
Chunk 127
---
 to product reimbursements6,842 5,380 Royalties and milestones accounts receivable1,183 786 Other receivables440 333 Total receivables$18,266 $10,509 

 As of June 30, 2025, and December 31, 2024, no reserve or allowance for doubtful accounts had been established. 

G.    Stock and Warrants

Authorized, Issued, and Outstanding Common SharesAs of June 30, 2025, and December 31, 2024, the Company had authorized shares of common stock of 250,000,000 shares. Of the authorized shares, 56,659,896 and 55,246,401 shares of common stock were issued as of June 30, 2025, and December 31, 2024, respectively, and 55,084,204 and 53,670,709 shares of common stock were outstanding as of June 30, 2025, and December 31, 2024, respectively.As of June 30, 2025, and December 31, 2024, the Company had reserved authorized shares of common stock for future issuance as follows:June 30,2025December 31,2024Outstanding awards under equity incentive plans7,395,0437,789,658Outstanding common stock warrants5,483,5275,483,537Possible future issuances under equity incentive plans6,308,8605,383,165Possible future issuances under employee stock purchase plans1,055,6851,148,012Total common shares reserved for future issuance20,243,11519,804,372

19

Common Stock ActivityThe following table summarizes common stock activity for the three and six months ended June 30, 2025:Shares of Common StockBalance as of January 1, 202553,670,709Common stock issued as compensation to third parties9,306Common stock issued as a result of stock options exercised or released999,338Warrants issued as a result of stock warrants exercised10Balance as of March 31, 202554,679,363Common stock issued as a result of stock options exercised or released312,514Common stock issued as a result of the Employee Stock Purchase Plan92,327Balance as of June 30, 202555,084,204Authorized, Issued, and Outstanding Preferred StockAs of June 30, 2025, and December